Glutamate dehydrogenase: Potential therapeutic targets for neurodegenerative disease
- 26 April 2023
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 950, 175733
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Zhejiang Province
This publication has 136 references indexed in Scilit:
- Glutaminolysis Activates Rag-mTORC1 SignalingMolecular Cell, 2012
- The structure and allosteric regulation of mammalian glutamate dehydrogenaseArchives of Biochemistry and Biophysics, 2012
- Green Tea Polyphenols Control Dysregulated Glutamate Dehydrogenase in Transgenic Mice by Hijacking the ADP Activation SiteJournal of Biological Chemistry, 2011
- 13N as a tracer for studying glutamate metabolismNeurochemistry International, 2011
- Estrogen Modification of Human Glutamate Dehydrogenases Is Linked to Enzyme Activation StateJournal of Biological Chemistry, 2010
- Human GLUD2 Glutamate Dehydrogenase Is Expressed in Neural and Testicular Supporting CellsJournal of Biological Chemistry, 2010
- Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onsetEuropean Journal of Human Genetics, 2009
- Novel Inhibitors Complexed with Glutamate DehydrogenaseJournal of Biological Chemistry, 2009
- Proteomics-Determined Differences in the Concanavalin-A-Fractionated Proteome of Hippocampus and Inferior Parietal Lobule in Subjects with Alzheimer’s Disease and Mild Cognitive Impairment: Implications for Progression of ADJournal of Proteome Research, 2008
- High Throughput Screening Reveals Several New Classes of Glutamate Dehydrogenase InhibitorsBiochemistry, 2007